Abstract
Abstract5′-end modifications play key roles in determining RNA fates. Phospho-methylation is a noncanonical cap occurring on either 5′-PPP or 5′-P ends. We used ChemRAP, in which affinity purification of cellular proteins with chemically synthesized modified RNAs is coupled to quantitative proteomics, to identify 5′-Pme “readers”. We show that 5′-Pme is directly recognized by EPRS, the central subunit of the multisynthetase complex (MSC), through its linker domain, which has previously been involved in key noncanonical EPRS and MSC functions. We further determine that the 5′-Pme writer BCDIN3D regulates the binding of EPRS to specific mRNAs, either at coding regions rich in MSC codons, or around start codons. In the case of LRPPRC (leucine-rich pentatricopeptide repeat containing), a nuclear-encoded mitochondrial protein associated with the French Canadian Leigh syndrome, BCDIN3D deficiency abolishes binding of EPRS around its mRNA start codon, increases its translation but ultimately results in LRPPRC mislocalization. Overall, our results suggest that BCDIN3D may regulate the translation of specific mRNA via RNA-5′-Pme.
Funder
Welch Foundation
HHS | NIH | National Institute of General Medical Sciences
DOD | USA | MEDCOM | Congressionally Directed Medical Research Programs
Storm Therapeutics
UT | UT | College of Natural Sciences, University of Texas at Austin
Structural Genomics Consortium
AbbVie US | AbbVie Canada
Bayer AG | Bayer Canada
Boehringer Ingelheim
Canada Foundation for Innovation
Eshelman Institute for Innovation
Genome Canada
Innovative Medicines Initiative
Janssen
Merck KGaA
Darmstadt, Germany, MSD
Novartis AG | Novartis Pharma
MDECEC | Ontario Ministry of Research and Innovation
Innovation and Science
Pfizer
São Paulo Research Foundation-FAPESP
Takeda
Wellcome
Publisher
Springer Science and Business Media LLC